Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • VERTEX PHARMACEUTICALS INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 832.10 M 460.87 M 704.63 M 361.16 M 392.32 M
    Net Receivables 23.49 M 31.32 M 62.92 M 20.60 M 11.89 M
    Total Inventories 0.00 0.00 0.00 0.00 0.00
    Progress Payments & Others 0.00 0.00 0.00 0.00 0.00
    Prepaid Expenses 4.66 M 3.86 M 3.30 M 2.50 M 4.35 M
    Other Current Assets 11.99 M 0.00 0.00 0.00 0.00
    Current Assets Total 867.58 M 496.85 M 771.41 M 385.06 M 406.71 M
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 30.26 M 37.18 M 87.38 M 106.70 M 18.86 M
    Property, Plant & Equipment Net 68.33 M 66.51 M 61.54 M 54.53 M 64.22 M
    Property, Plant & Equipment Gross 261.91 M 239.89 M 213.52 M 202.36 M 191.02 M
    Accumulated Depreciation 193.58 M 173.38 M 151.98 M 147.83 M 126.79 M
    Other Assets 14.31 M 934,000.00 1.25 M 2.71 M 55.65 M
    Deferred Charges 932,000.00 0.00 9.30 M — —
    Tangible Other Assets 14.31 M 2.71 M 54.72 M 5.60 M 1.34 M
    Intangible Other Assets 0.00 0.00 0.00 — —
    Total Assets 980.48 M 601.48 M 921.58 M 549.00 M 545.45 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 0.00 20.00 M 101.75 M 0.00 0.00
    Accrued Payroll 39.84 M 25.78 M 25.12 M 15.83 M 11.11 M
    Income Taxes Payable — — — — —
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 124.97 M 120.75 M 108.78 M 78.20 M 135.97 M
    Current Liabilities Total 216.56 M 199.28 M 251.01 M 100.24 M 153.74 M
    Long Term Debt 287.50 M 0.00 20.00 M 180.10 M 335.00 M
    Provision for Risks & Charges — — — — —
    Deferred Taxes 0.00 0.00 0.00 0.00 0.00
    Deferred Income 209.80 M 101.22 M 116.30 M 851,000.00 18.34 M
    Deferred Tax Liability in Untaxed Reserves — — — — —
    Other Liabilities 27.74 M 29.69 M 28.34 M 28.63 M 2.92 M
    Total Liabilities 741.60 M 330.18 M 415.64 M 309.82 M 510.01 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 238.87 M 271.30 M 505.94 M 239.18 M 35.44 M
    Common Stock 1.49 M 1.31 M 1.24 M 1.08 M 807,000.00
    Capital Surplus 2.28 B 1.86 B 1.70 B 1.24 B 833.83 M
    Revaluation Reserves — — — — —
    Other Appropriated Reserves 3.17 M 881,000.00 -962,000.00 -16.28 M -13.03 M
    Unappropriated (Free) Reserves 0.00 0.00 0.00 0.00 0.00
    Retained Earnings -2.05 B -1.59 B -1.20 B -989.58 M -786.17 M
    Equity in Untaxed Reserves — — — — —
    ESOP Guarantees — — — — —
    Unrealized Foreign Exchange Gain (Loss) — — — — —
    Unrealized Gain (Loss) on Marketable Securities — — — — —
    Treasury Stock 0.00 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 980.48 M 601.48 M 921.58 M 549.00 M 545.45 M
    Common Shares Outstanding 151.25 M 132.88 M 126.12 M 108.15 M 80.76 M